当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 现金流量表

华海药业

(600521)

  

流通市值:251.93亿  总市值:251.93亿
流通股本:15.00亿   总股本:15.00亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金7,236,077,681.414,861,207,741.242,486,694,087.38,709,986,888.79
  收到的税费返还181,071,466.82138,042,500.9864,777,189.24216,564,223.97
  收到其他与经营活动有关的现金195,314,130.33151,444,07138,527,999.18245,623,358.44
  经营活动现金流入小计7,612,463,278.565,150,694,313.222,589,999,275.729,172,174,471.2
  购买商品、接受劳务支付的现金2,599,702,923.981,659,326,187867,948,925.112,607,895,934.19
  支付给职工以及为职工支付的现金1,399,876,309.06979,894,020.56559,971,235.221,865,521,482.47
  支付的各项税费488,509,447.42342,090,467.9172,558,207.83608,004,159.62
  支付其他与经营活动有关的现金1,596,164,813.161,071,333,581.69590,888,293.982,860,664,326.03
  经营活动现金流出小计6,084,253,493.624,052,644,257.152,191,366,662.147,942,085,902.31
  经营活动产生的现金流量净额1,528,209,784.941,098,050,056.07398,632,613.581,230,088,568.89
二、投资活动产生的现金流量:
  收回投资收到的现金35,426,320.192,144,342.95-116,266,648.6
  取得投资收益收到的现金---2,276,291.74
  处置固定资产、无形资产和其他长期资产收回的现金净额27,159,271.3325,824,336.324,092,6859,952,006
  处置子公司及其他营业单位收到的现金净额152,231,347.1152,231,347.1--
  收到的其他与投资活动有关的现金---89,150,000
  投资活动现金流入小计214,816,938.62180,200,026.374,092,685217,644,946.34
  购建固定资产、无形资产和其他长期资产支付的现金1,077,833,420.99722,467,532.32446,392,949.921,966,048,669.65
  投资支付的现金---30,000,000
  取得子公司及其他营业单位支付的现金6,530,265.326,530,265.32--
  支付其他与投资活动有关的现金--134,418,652.989,150,000
  投资活动现金流出小计1,084,363,686.31728,997,797.64580,811,602.822,085,198,669.65
  投资活动产生的现金流量净额-869,546,747.69-548,797,771.27-576,718,917.82-1,867,553,723.31
三、筹资活动产生的现金流量:
  吸收投资收到的现金---591,515,088.97
  取得借款收到的现金4,747,370,529.391,480,257,765.151,180,000,0004,725,846,856.91
  收到其他与筹资活动有关的现金---200,000,000
  筹资活动现金流入小计4,747,370,529.391,480,257,765.151,180,000,0005,517,361,945.88
  偿还债务支付的现金4,263,180,248.911,271,254,853.91507,670,7374,303,857,918
  分配股利、利润或偿付利息支付的现金283,890,856.98246,980,740.437,283,948.28558,051,627.45
  其中:子公司支付给少数股东的股利、利润23,741,60523,741,605-11,870,802.5
  支付其他与筹资活动有关的现金18,040,215.6413,605,139.7110,400,036.9938,382,608.77
  筹资活动现金流出小计4,565,111,321.531,531,840,734.02555,354,722.274,900,292,154.22
  筹资活动产生的现金流量净额182,259,207.86-51,582,968.87624,645,277.73617,069,791.66
四、汇率变动对现金及现金等价物的影响-150,330,648.9-106,848,032.89-47,290,591.29-10,650,693.14
五、现金及现金等价物净增加额690,591,596.21390,821,283.04399,268,382.2-31,046,055.9
  加:期初现金及现金等价物余额1,446,554,164.111,446,554,164.111,446,554,164.111,477,600,220.01
  期末现金及现金等价物余额2,137,145,760.321,837,375,447.151,845,822,546.311,446,554,164.11
补充资料:
  净利润-767,088,108.01-227,329,393.11
  资产减值准备-18,906,386.57-205,463,675.96
  固定资产和投资性房地产折旧-481,960,560.97-888,153,436.39
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-481,960,560.97-888,153,436.39
  无形资产摊销-64,040,393.5-123,310,912.26
  长期待摊费用摊销-5,968,923.47-13,238,385.18
  处置固定资产、无形资产和其他长期资产的损失--23,330,595.34--943.66
  固定资产报废损失-1,608,207.68-13,497,071.17
  公允价值变动损失--9,596,469.37--48,739,845.24
  财务费用-216,660,637.19-267,297,570.98
  投资损失--211,124,981.07--20,710,977.24
  递延所得税-8,691,195.79--5,107,155.12
  其中:递延所得税资产减少-8,691,195.79--5,107,155.12
  存货的减少-98,743,736.31--471,605,242.36
  经营性应收项目的减少-37,635,444.26--126,337,241.49
  经营性应付项目的增加--373,490,689.92-165,021,079.43
  其他-7,444,968.45-8,312,103.96
  现金的期末余额-1,837,375,447.15-1,446,554,164.11
  减:现金的期初余额-1,446,554,164.11-1,477,600,220.01
  现金及现金等价物的净增加额-390,821,283.04--31,046,055.9
公告日期2026-10-302026-08-272026-04-302026-04-30
审计意见(境内)标准无保留意见
TOP↑